PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $165,000 | +10.7% | 43,483 | +48.4% | 0.00% | +33.3% |
| Q4 2019 | $149,000 | +0.7% | 29,301 | -0.0% | 0.00% | 0.0% |
| Q3 2019 | $148,000 | -17.3% | 29,315 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $179,000 | +32.6% | 29,026 | +0.0% | 0.00% | +50.0% |
| Q1 2019 | $135,000 | +10.7% | 29,018 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $122,000 | -3.2% | 28,992 | +44.8% | 0.00% | 0.0% |
| Q3 2018 | $126,000 | +0.8% | 20,019 | +28.4% | 0.00% | 0.0% |
| Q2 2018 | $125,000 | – | 15,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |